These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6627598)

  • 1. The in vivo cytotoxic activity of procarbazine and procarbazine metabolites against L1210 ascites leukemia cells in CDF1 mice and the effects of pretreatment with procarbazine, phenobarbital, diphenylhydantoin, and methylprednisolone upon in vivo procarbazine activity.
    Shiba DA; Weinkam RJ
    Cancer Chemother Pharmacol; 1983; 11(2):124-9. PubMed ID: 6627598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Major isozymes of rat liver microsomal cytochrome P-450 involved in the N-oxidation of N-isopropyl-alpha-(2-methylazo)-p-toluamide, the azo derivative of procarbazine.
    Prough RA; Brown MI; Dannan GA; Guengerich FP
    Cancer Res; 1984 Feb; 44(2):543-8. PubMed ID: 6692359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylazoxyprocarbazine, the active metabolite responsible for the anticancer activity of procarbazine against L1210 leukemia.
    Swaffar DS; Horstman MG; Jaw JY; Thrall BD; Meadows GG; Harker WG; Yost GS
    Cancer Res; 1989 May; 49(9):2442-7. PubMed ID: 2706632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic activation of the terminal N-methyl group of N-isopropyl-alpha-(2-methylhydrazino)-p-toluamide hydrochloride (procarbazine).
    Moloney SJ; Wiebkin P; Cummings SW; Prough RA
    Carcinogenesis; 1985 Mar; 6(3):397-401. PubMed ID: 3978755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxicity and DNA damage caused by the azoxy metabolites of procarbazine in L1210 tumor cells.
    Erikson JM; Tweedie DJ; Ducore JM; Prough RA
    Cancer Res; 1989 Jan; 49(1):127-33. PubMed ID: 2908840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of the cytotoxic action of mafosfamide by N-isopropyl-p-formylbenzamide, a metabolite of procarbazine.
    Maki PA; Sladek NE
    Cancer Res; 1991 Aug; 51(16):4170-5. PubMed ID: 1868438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative metabolism of N-isopropyl-alpha-(2-methylazo)-p-toluamide (azoprocarbazine) by rodent liver microsomes.
    Wiebkin P; Prough RA
    Cancer Res; 1980 Oct; 40(10):3524-9. PubMed ID: 7438038
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro and in vivo evidence for the formation of methyl radical from procarbazine: a spin-trapping study.
    Goria-Gatti L; Iannone A; Tomasi A; Poli G; Albano E
    Carcinogenesis; 1992 May; 13(5):799-805. PubMed ID: 1316811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Separate mechanisms for procarbazine spermatotoxicity and anticancer activity.
    Horstman MG; Meadows GG; Yost GS
    Cancer Res; 1987 Mar; 47(6):1547-50. PubMed ID: 3815355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in the toxicity and antitumor activity of methyl-CCNU in mice following pretreatment with either phenobarbital or SKF 525A.
    Klubes P; Miller HG; Cerna I; Trevithick J
    Cancer Treat Rep; 1979; 63(11-12):1901-7. PubMed ID: 526922
    [No Abstract]   [Full Text] [Related]  

  • 11. Mutagenic and chemotherapeutic activity in L1210 leukemia of several monofunctional alkylating agents.
    Schmid FA; Otter GM; Mehta BM
    Cancer Res; 1985 Jan; 45(1):40-4. PubMed ID: 3965147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative metabolism of N-isopropyl-alpha-(2-methylhydrazino)-p-toluamide hydrochloride (procarbazine) by rat liver microsomes.
    Dunn DL; Lubet RA; Prough RA
    Cancer Res; 1979 Nov; 39(11):4555-63. PubMed ID: 498087
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on the metabolism of procarbazine by mass spectrometry.
    Kuttab SH; Tanglertpaibul S; Vouros P
    Biomed Mass Spectrom; 1982 Feb; 9(2):78-84. PubMed ID: 7059663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further studies on the tumor-inhibitory and tumor-inducing properties of N-isopropyl-alpha-(2-methylhydrazino)-p-toluamide hydrochloride (procarbazine hydrochloride).
    Grunberg E; Prince HN
    Chemotherapy; 1969; 14(2):65-76. PubMed ID: 5394393
    [No Abstract]   [Full Text] [Related]  

  • 15. Metabolism of procarbazine [N-isopropyl-alpha-(2-methylhydrazino)-p-toluamide HCl].
    Prough RA; Coomes MW; Cummings SW; Wiebkin P
    Adv Exp Med Biol; 1981; 136 Pt B():983-96. PubMed ID: 7046391
    [No Abstract]   [Full Text] [Related]  

  • 16. A structural modification study of procarbazine.
    Weinstock LT; Cheng CC
    J Med Chem; 1979 May; 22(5):594-7. PubMed ID: 458813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-enzymatic activation of procarbazine to active cytotoxic species.
    Swaffar DS; Pomerantz SC; Harker WG; Yost GS
    Oncol Res; 1992; 4(2):49-58. PubMed ID: 1596582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potentiation of barbiturate-induced narcosis by procarbazine.
    Lee IP; Lucier GW
    J Pharmacol Exp Ther; 1976 Mar; 196(3):586-93. PubMed ID: 1263114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined antitumor effect of cyclophosphamide and bromodeoxyuridine in BDF1 mice bearing L1210 ascites tumors.
    Kagawa Y; Noge I; Higashigawa M; Komada Y
    Biol Pharm Bull; 2008 Jan; 31(1):57-61. PubMed ID: 18175942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential antitumor agents: procarbazine analogs and other methylhydrazine derivatives.
    Beisler JA; Peng GW; Driscoll JS
    J Pharm Sci; 1977 Jun; 66(6):849-52. PubMed ID: 874788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.